Financials Albemarle Corporation

Equities

ALB

US0126531013

Specialty Chemicals

Real-time Estimate Cboe BZX 01:35:45 2024-05-17 pm EDT 5-day change 1st Jan Change
131.4 USD +1.70% Intraday chart for Albemarle Corporation +1.39% -9.04%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,745 15,705 27,346 25,406 16,955 15,183 - -
Enterprise Value (EV) 1 10,182 18,530 29,301 27,124 20,232 19,713 19,381 20,114
P/E ratio 14.5 x 41.9 x 221 x 9.49 x 10.8 x 44.5 x 9.71 x 10.7 x
Yield 2.01% 1.04% 0.67% 0.73% - 1.24% 1.26% 1.41%
Capitalization / Revenue 2.16 x 5.02 x 8.22 x 3.47 x 1.76 x 2.57 x 2.1 x 1.8 x
EV / Revenue 2.84 x 5.92 x 8.8 x 3.71 x 2.1 x 3.34 x 2.68 x 2.38 x
EV / EBITDA 9.82 x 22.6 x 33.6 x 7.8 x 6 x 15.1 x 10.7 x 9.29 x
EV / FCF -76.9 x -359 x -48.1 x 42 x -24.6 x -36 x -358 x 50.1 x
FCF Yield -1.3% -0.28% -2.08% 2.38% -4.07% -2.78% -0.28% 2%
Price to Book 1.97 x 3.69 x 4.86 x 3.2 x 1.8 x 1.44 x 1.4 x 1.34 x
Nbr of stocks (in thousands) 106,033 106,457 116,976 117,153 117,353 117,527 - -
Reference price 2 73.04 147.5 233.8 216.9 144.5 129.2 129.2 129.2
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,589 3,129 3,328 7,320 9,617 5,901 7,244 8,440
EBITDA 1 1,037 818.7 871 3,476 3,370 1,306 1,811 2,166
EBIT 1 823.3 586.8 617 3,175 2,940 756.7 1,317 1,533
Operating Margin 22.94% 18.75% 18.54% 43.37% 30.57% 12.82% 18.18% 18.17%
Earnings before Tax (EBT) 1 563 373.5 133.6 2,433 246.7 -417.9 1,287 1,926
Net income 1 533.2 375.8 123.7 2,690 1,573 365.1 1,573 2,909
Net margin 14.86% 12.01% 3.72% 36.75% 16.36% 6.19% 21.71% 34.47%
EPS 2 5.020 3.520 1.060 22.84 13.36 2.903 13.30 12.07
Free Cash Flow 1 -132.4 -51.56 -609.4 646.2 -824 -547.8 -54.08 401.7
FCF margin -3.69% -1.65% -18.31% 8.83% -8.57% -9.28% -0.75% 4.76%
FCF Conversion (EBITDA) - - - 18.59% - - - 18.55%
FCF Conversion (Net income) - - - 24.02% - - - 13.81%
Dividend per Share 2 1.470 1.540 1.560 1.580 - 1.602 1.626 1.827
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 894.2 1,128 1,480 2,092 2,621 2,580 2,370 2,311 2,356 1,361 1,379 1,522 1,721 1,537 1,612
EBITDA 1 228.7 431.9 610.2 1,190 1,244 1,596 1,032 453.3 289.1 291.2 291.8 325.8 388.1 375.5 407
EBIT 1 160.5 365.4 539.2 1,112 1,158 1,508 939.2 347.8 145 167.5 177 231.2 265.4 204.6 239.2
Operating Margin 17.95% 32.4% 36.44% 53.17% 44.19% 58.46% 39.62% 15.05% 6.15% 12.31% 12.83% 15.19% 15.43% 13.31% 14.84%
Earnings before Tax (EBT) 1 -8.062 299.6 401.5 869.3 863.1 1,157 168.4 -158.2 -921 -167.6 -48.1 -80.1 -26.05 - -
Net income 1 -3.824 253.4 406.8 897.2 1,132 1,239 650 302.5 -617.7 -9.136 93.74 87.89 122.7 362 390
Net margin -0.43% 22.47% 27.49% 42.89% 43.21% 48% 27.43% 13.09% -26.22% -0.67% 6.8% 5.77% 7.13% 23.56% 24.2%
EPS 2 -0.0300 2.150 3.460 7.610 9.600 10.51 5.520 2.570 -5.260 -0.0800 0.6833 0.6333 0.9333 3.080 3.320
Dividend per Share 2 0.3900 0.3950 0.3950 0.3950 0.3950 0.4000 0.4000 0.4000 - - 0.4000 0.4000 0.4000 0.5126 0.5192
Announcement Date 2/16/22 5/4/22 8/3/22 11/2/22 2/15/23 5/3/23 8/2/23 11/1/23 2/14/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,437 2,825 1,955 1,718 3,277 4,530 4,198 4,931
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.351 x 3.451 x 2.245 x 0.4943 x 0.9723 x 3.469 x 2.317 x 2.276 x
Free Cash Flow 1 -132 -51.6 -609 646 -824 -548 -54.1 402
ROE (net income / shareholders' equity) 17.1% 9.16% 8.31% 19% 30.1% 3.45% 7.93% 6.9%
ROA (Net income/ Total Assets) 7.37% 3.7% 4.39% 19.6% 15.5% 2.38% 5.98% 8.85%
Assets 1 7,237 10,156 2,817 13,745 10,128 15,358 26,320 32,881
Book Value Per Share 2 37.10 39.90 48.10 67.80 80.20 89.80 92.20 96.40
Cash Flow per Share 2 6.770 7.480 2.970 16.20 11.30 13.90 12.10 17.50
Capex 1 852 850 954 1,262 2,149 1,732 1,685 1,753
Capex / Sales 23.73% 27.18% 28.66% 17.24% 22.35% 29.35% 23.26% 20.77%
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
129.2 USD
Average target price
154.4 USD
Spread / Average Target
+19.48%
Consensus
  1. Stock Market
  2. Equities
  3. ALB Stock
  4. Financials Albemarle Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW